Seelos therapeutics announces issuance of a patent for trehalose (sls-005) in israel

New york, dec. 21, 2020 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today that it has been issued israeli patent number 241757...
SEEL Ratings Summary
SEEL Quant Ranking